Product Information
BDA-366 is a molecule that has potent antitumor activity. It induces apoptosis in cancer cells by dephosphorylating the BCL-2 gene, which leads to the release of pro-apoptotic protein, such as BAX, and the activation of caspases. In addition, BDA-366 has been shown to inhibit proliferation of hematopoietic cells and induce lymphocytic leukemia cell death. Novartis has developed an antibody against BDA-366 to counteract its effects.
Chemical properties
Technical inquiry about: 3D-FB145123 BDA-366
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.